Double-S arm for Erectile Dysfunction

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stanford Healthcare, Stanford Hospital, Stanford, CA
Erectile Dysfunction
Double-S - Device
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: baseline and up to 1 month post-baseline

Month 1
Change in modified International Index of Erectile Dysfunction score

Trial Safety

Trial Design

1 Treatment Group

Double-S arm
1 of 1
Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: Double-S arm · No Placebo Group · N/A

Double-S arm
Device
Experimental Group · 1 Intervention: Double-S · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and up to 1 month post-baseline

Trial Background

Michael Eisenberg, Michael Eisenberg M.D.
Principal Investigator
Stanford University
Closest Location: Stanford Healthcare, Stanford Hospital · Stanford, CA
N/AFirst Recorded Clinical Trial
2 TrialsResearching Erectile Dysfunction
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · Male Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.